BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 1227911)

  • 1. [Pharmacokinetics of dioxonium].
    Veveris MM; Kimenis AA; Gilev AP; Sokolov GP; Giller SA
    Farmakol Toksikol; 1975; 38(6):669-72. PubMed ID: 1227911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Species sensitivity to dioxonium].
    Kimenis AA; Veveris MM
    Farmakol Toksikol; 1973; 36(5):690-2. PubMed ID: 4802327
    [No Abstract]   [Full Text] [Related]  

  • 3. A comparative clinical study of dioxonium and pancuronium as muscle relaxants in small children.
    Iisalo EU; Kanto JH
    Int J Clin Pharmacol Ther Toxicol; 1981 Jun; 19(6):260-5. PubMed ID: 7030973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of muscular relaxants and anesthetic fluothane on activity of Ca2+-dependent ATPase of skeletal muscle sarcolemma].
    Mozgovaia EN; Brazaluk AZ
    Ukr Biokhim Zh (1978); 1978; 50(2):230-3. PubMed ID: 149403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The pharmacology of some 1,3-dioxolanes, 1,3-oxathiolanes and 1,3-dithiolanes].
    Bekemeier H; Köster D
    Pharmazie; 1976; 31(5):317-23. PubMed ID: 959287
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pharmacology of a new muscle relaxant--dioxonium].
    Kimenis AA; Klusha VE; Ginters IaIa
    Farmakol Toksikol; 1972; 35(2):172-5. PubMed ID: 4259940
    [No Abstract]   [Full Text] [Related]  

  • 7. [Change in behavior of mice and rats under the effect of dimethyl-2,2 hydroxymethyl-4 dioxolanne-1,3 (glycerol acetonide)].
    Cheav SL; Ziade FF; Foussard-Blanpin O
    Ann Pharm Fr; 1986; 44(6):487-94. PubMed ID: 3619328
    [No Abstract]   [Full Text] [Related]  

  • 8. Phencyclidine-like discriminative stimulus properties of the stereoisomers of dioxadrol.
    Slifer BL; Balster RL
    Subst Alcohol Actions Misuse; 1984-1985; 5(6):273-80. PubMed ID: 6545061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prospidin-C14 blood level, distribution in the organs and tissues and excretion from the body of rats].
    Bogomolova NS; Suskova VS; Minakova SM; Chernov VA; Serebriakov NG
    Farmakol Toksikol; 1975; 38(6):722-8. PubMed ID: 1227923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of prulifloxacin. 2nd communication: pharmacokinetics and effect on hepatic drug-metabolizing enzyme activities after repeated administration and transfer into fetus and milk after a single administration in rats.
    Okuyama Y; Momota K; Morino A
    Arzneimittelforschung; 1997 Mar; 47(3):285-92. PubMed ID: 9105547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for separation of anesthetic activity from prototypic phencyclidine action in drug discrimination by molecular modification of dioxadrol, a phencyclidine-like dissociative anesthetic.
    Harrison EA; Rafferty MF; Rice KC; Creveling CR; Winger GD; Woods JH; Jacobson AE
    NIDA Res Monogr; 1984; 55():90-6. PubMed ID: 6100507
    [No Abstract]   [Full Text] [Related]  

  • 12. [Experience in the use of a new Soviet myorelaxant, dioxonium, in anesthesiology].
    Vanevskiĭ VL; Kargapolov LN
    Vestn Khir Im I I Grek; 1970 Jun; 104(6):74-7. PubMed ID: 5489216
    [No Abstract]   [Full Text] [Related]  

  • 13. Enantiomeric and diastereomeric dioxadrols: behavioral, biochemical and chemical determination of the configuration necessary for phencyclidine-like properties.
    Jacobson AE; Harrison EA; Mattson MV; Rafferty MF; Rice KC; Woods JH; Winger G; Solomon RE; Lessor RA; Silverton JV
    J Pharmacol Exp Ther; 1987 Oct; 243(1):110-7. PubMed ID: 2822892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discriminative stimulus and reinforcing properties of etoxadrol and dexoxadrol in monkeys.
    Brady KT; Woolverton WL; Balster RL
    J Pharmacol Exp Ther; 1982 Jan; 220(1):56-62. PubMed ID: 6118431
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacokinetics and dynamics of muscle relaxants.
    Stanski DR; Sheiner LB
    Anesthesiology; 1979 Aug; 51(2):103-5. PubMed ID: 453608
    [No Abstract]   [Full Text] [Related]  

  • 16. Metabolism, pharmacokinetics, tissue distribution, and excretion of [14C]CP-424391 in rats.
    Khojasteh-Bakht SC; O'donnell JP; Fouda HG; Potchoiba MJ
    Drug Metab Dispos; 2005 Jan; 33(1):190-9. PubMed ID: 15486077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absorption, distribution, metabolism, and excretion of donepezil (Aricept) after a single oral administration to Rat.
    Matsui K; Mishima M; Nagai Y; Yuzuriha T; Yoshimura T
    Drug Metab Dispos; 1999 Dec; 27(12):1406-14. PubMed ID: 10570021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of dioxonium as a neuromuscular blocking agent.
    Salmenperä M; Tammisto T
    Acta Anaesthesiol Scand; 1980 Oct; 24(5):395-8. PubMed ID: 7468129
    [No Abstract]   [Full Text] [Related]  

  • 19. Absorption, distribution, metabolism and excretion of [14C]ebastine after a single administration in rats.
    Fujii T; Matsumoto S; Amejima H; Hatoyama T; Nakao M; Kagemoto A; Tanaka K; Miyazaki H
    Arzneimittelforschung; 1994 Apr; 44(4):527-38. PubMed ID: 7912071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of kappa agonists and dexoxadrol on the acquisition of conditional discriminations in monkeys.
    Moerschbaecher JM; Brocklehurst C; Devia C; Faust WB
    J Pharmacol Exp Ther; 1987 Nov; 243(2):737-44. PubMed ID: 2824758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.